Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A study to compare a two novel ketamine wafer formulations to intravenous ketamine in healthy adult volunteers.


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12617000140358

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: 13/02/2017

Brief Summary: Participants will be admitted to the research clinical for three separate inpatient periods, each period separated by a minimum of 3 days. Participants will check in the afternoon before planned dosing and will stay inpatient for 24 hours after study medication for each inpatient period. In one period, a single dose of intravenous ketamine 10 mg will be administered and in the two other periods a single 25 mg ketamine wafer (two different formulations) will be administered under the tongue. No food or drink except water is allowed starting 10 hours before each study medication dose and for 4 hours after dosing. Water is restricted 1 hour before and after dosing.

Countries:
  • Australia


Total execution time in seconds: 0.084372043609619